Publications by authors named "M Coste-Burel"

Article Synopsis
  • Enterovirus D68 (EV-D68) infections can cause severe respiratory issues and acute flaccid myelitis, with a significant rise reported during the fall-winter season of 2021-2022 across Europe.
  • The study by the European Non-Polio Enterovirus Network (ENPEN) analyzed over 10,481 samples from 19 countries, identifying 1,004 as EV-D68, predominantly affecting young children, where 37.9% required hospitalization.
  • Additionally, genetic analyses uncovered two new B3-derived lineages without regional patterns, indicating a notable impact of the infections and the emergence of new virus strains.
View Article and Find Full Text PDF
Article Synopsis
  • A study conducted in a French university hospital investigated the prevalence of SARS-CoV-2 in asymptomatic children who were routinely screened before surgery during the pandemic.
  • The retrospective analysis included 816 test samples, revealing a low prevalence of 0.49% positivity, with half of the positive cases linked to close contacts with adults who were infected.
  • The findings suggest that asymptomatic children had a low rate of SARS-CoV-2 infection during the initial phases of the pandemic in France.
View Article and Find Full Text PDF

In May 2019, a measles outbreak occurred in the French subregion of Loire-Atlantique, particularly affecting Roma settlements. Various obstacles hindered the implementation of postexposure measures among Roma population, resulting in the spread of the cases to other settlements. Suspected cases of measles were immediately investigated and concerned settlements were visited for measles-mumps-rubella (MMR) vaccination.

View Article and Find Full Text PDF
Article Synopsis
  • Patients with inflammatory bowel disease (IBD) treated with infliximab or vedolizumab showed a COVID-19 prevalence similar to the general French population before vaccinations, with only 4.5% confirmed cases.
  • Factors increasing COVID-19 risk included using public transport and living in urban settings, while treatment type or disease activity did not affect infection rates.
  • Recommendations suggest that maintaining sanitary barrier measures is essential for IBD patients on biological therapies to minimize the risk of SARS-CoV-2 infection.
View Article and Find Full Text PDF